Stylianos Loukides (Voula, Athens, Greece), Pieter-Paul W. Hekking (Amsterdam, Netherlands), Juan Luis García Rivero (Mogro (Cantabria), Spain), Florence Schleich (Liège, Belgium)
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients Jens Schreiber (Magdeburg, Germany), Jens Schreiber, Kristin Garg, Claudia Mailaender
| |
Respiratory outcomes in young adults following extremely preterm birth Joanne Beckmann (London, United Kingdom), Joanne Beckmann, Kate Bennett, Charlotte Bolton, Neil Marlow, John Hurst
| |
Clinical features of chronic obstructive pulmonary disease in never smokers Shin young Kim (Seuol, Republic of Korea), Shin young Kim, Hyoung Kyu Yoon, Tai joon An, Chan kwon Park, Sei Won Kim
| |
Risk for adverse outcomes in asthma: Assess to impress! Lilia Maia Santos (Lorvão - Penacova, Portugal), Lilia Maia Santos, Cláudia Chaves Loureiro
| |
Predictors of lung function deterioration in COPD Rossella D'Amato (S/C de Tenerife, Spain), Rossella D’Amato, Juan Marco Figueira Gonçalves, Ignacio García Talavera
| |
Variability of total serum IgE in moderate-to-severe asthmatic patients Antoine Poskin (Vilvoorde, Belgium), Renaud Louis, Charles Pilette, Olivier Michel, Alain Michils, Guy Brusselle, Lieven Dupont, Antoine Poskin, Jan Van Schoor, Stefaan Vancayzeele, Sandra Gurdain
| |
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Sebastian Fähndrich (Homburg/Saar, Germany), Sebastian Fähndrich, Nikolas Bernhard, Philipp M. Lepper, Claus Vogelmeier, Robert Bals
| |
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Polyxeni Ntontsi (Athens, Greece), Polyxeni Ntontsi, Stelios Loukides, Petros Bakakos, Konstantinos Kostikas, Georgios Papatheodorou, Evgenia Ppathanassiou, Anastasia Papaporfyriou, Elissavet Konstantellou, Hillas Georgios, Nikolaos Koulouris, Spyridon Papiris, Andriana Papaioannou
| |
Heterogeneity of group D in the new GOLD classification of COPD Richa Mittal (New Delhi, India), Richa Mittal, Sunil Chhabra
| |
Significance of quantitative radiological phenotypes of COPD on BODE index Avinash Jain (Varanasi, India), Avinash Jain, S.K. Agrawal
| |
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma Fabio L. M. Ricciardolo (Orbassano (Turin), Italy), Fabio L.M. Ricciardolo, Valentina Sorbello, Davide Vallese, Gian Mario Massaglia, Gabriella Favatà, Antonino Di Stefano
| |
CAT in COPD phenotypes (POPE study) Vladimír Koblížek (Hradec Králové, Czech Republic), Vladimír Koblízek, Attila Somfay, Jan Svancara, Ruzena Tkacova, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Zuzana Zbozinkova, Jurij Sorli, Alvis Krams, Marc Miravitlles, Arschang Valipour
| |
Prevalence of COPD in heroin smokers screened at substance misuse clinics Jennifer Furlong (Liverpool, United Kingdom), Jennifer Furlong, Rob Peat, Ryan Young, Tara Byrne, Doreen Russell, Tristan Elkin, Sandra Oelbaum, Hassan Burhan, Paul Walker, Sue Renwick
| |
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Vladimír Koblížek (Hradec Králové, Czech Republic), Vladimír Koblízek, Barbora Novotna, Jan Svancara, Michal Svoboda, Patrice Popelkova, Marek Plutinsky, Kristian Brat, Jaromir Zatloukal, Eva Volakova, Karel Hejduk, Eva Kocova, Michal Kopecky, Katerina Neumannova, Miroslava Fecaninova, Petr Safranek, Tomas Dvorak, Ondrej Sobotik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Marie Majerciakova, Pavlina Musilova, Jiri Jarkovsky
| |
Prevalence of refractory asthma in population with severe asthma Evgeny Kulikov (Tomsk, Russian Federation), Evgeny Kulikov, Ludmila Ogorodova, Ivan Deev, Natalya Kirillova, Sergey Fedosenko
| |
Vitamin D deficiency is associated with rapid decline in exercise capacity in male patients with COPD Yong Bum Park (Seoul, Republic of Korea), Yong Bum Park, Changhwan Kim, Ji Ye Jung, Yeon-Mok Oh, Sang-Do Lee, Kwang Ha Yoo
| |
Can emphysema predict exacerbations and changes in PFTs in COPD? Zvi G Fridlender (Jerusalem, Israel), Zvi G. Fridlender, Ron Kaufman, Dorit Shaham, Neville Berkman
| |
Clinical differences between emphysematous and non-emphysematous COPD Manu Madan (New Delhi, India), Manu Madan, Pawan Gupta, Richa Mittal, Sunil Chhabra
| |
Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Aliaksei Kadushkin (Minsk, Belarus), Aliaksei Kadushkin, Anatoli Tahanovich
| |
Use of clinical characteristics to predict spirometric classification of obstructive lung disease Steven Pascoe (Research Triangle Park, United States of America), Steven Pascoe, Wei Wu, Kathryn Collison, Linda Nelsen, Keele Wurst, Laurie Lee
| |